ProfessorShoumitro Deb

Overview

Current research.

Horizon2025 European consortium grant: INQLUDE-ID (Improvement of inclusion, empowerment, and quality of life of people with intellectual disabilities); UK project: SPEED (Shared decision making for mental health medicine prescribing in adults with intellectual disabilities): UK joint leads Professor Shoumitro Deb and Dr Gemma Unwin (University of Birmingham). (2027-2032).

National Institute for Health and Care research, UK, HTA programme: APPRAISE (Structured multi-stakeholder antipsychotic medicine opitimisation planning supported by SPECTROM staff training). Lead: Professor Shoumitro Deb; Joint-lead: Associate Professor Sameer Jauhar. (2026-2030).

Baily Thomas Charitable Trust: SUPPORT (Supported decision making for epilepsy management in adults with intellectual disabilities). Lead: Professor Shoumitro Deb; Joint-lead: Professor Rohit Shankar (University of Plymouth) (2027-2028).

John Paul II Cathedral University of Lubin, Poland: DISQIID-P (Diagnosing early symptoms of dementia in people with intellectual disabilities in Poland). Joint lead: Professor Ewa Domagała-Zyśk, Professor Stanislawa Byra, Poland and Professor Shoumitro Deb (2026-2027).

Department of Health and Aged Care, Australian Government. SPECTROM Australia (ASPIRE-Med): A mental health medicines training program. Barratt M, University of Canberra (lead), Deb S (co-lead), Bushell M, University of Canberra (co-lead), Simpson A, Monash Health, Bellon M, Flinders University, Koncz R, University of New South Wales (2025-2028).

National Institute for Health and Care Reserach, UK: RAPID COP (RAtionalising Psychotropic medications for adults with Intellectual Disabilities: sCOPing) Lead: Professor Shoumitro Deb (2025-2026). https://spectrom.wixsite.com/rapid-cop

Baily Thomas Charitable Fund, UK: EFFECT (Effectiveness of interventions for behaviours that challenge in adults with intellectual disabilities using UK primary care health records) jointly led by Professor Angela Hassiotis at UCL and Professor Shoumitro Deb at ICL (2024-2025).

National Institute for Health and Care Reserach, UK: SPECTROM PDP (SPECTROM Programme Development Project) Lead: Professor Shoumitro Deb (2023-2025). https://spectrom.wixsite.com/spectrompdp   

National Institute for Health and Care Reserach, UK: SPECTROM (Short-term Psycho-Education for Carers To Reduce Over Medication of people with intellectual disabilities) Lead: Professor Shoumitro Deb. https://spectrom.wixsite.com/project

 
Victorian Government & Life Without Barrier, Australia funded: PROMISE (Process Evaluation of a Practice Leadership Mentoring Model: SPECTROM) Lead: Professor Nathan Wilson, University of South Sydney, Australia, Co-lead: Professor Shoumitro Deb (2024-2026).

Senior Practitioner's Office, State of Victoria, Australia: DEPICT (Deprescribing psychotropics In adults with intellectual disabilities)  (2023-2025) Lead: Mandy Donley, Victoria Senior Parctoner Office, Australia(2023-2025) ).

National Institute for Health and Care Reserach, UK: AFTER (Aggression Following TBI: Effectiveness of Risperidone: a feasibility RCT) Lead: Professor Shoumitro Deb and Professor Mike Crawford.

Positions held (Ex).

World Health Organization (WHO)

Work Group member: ICD-11 Intellectual Developmental Disorder.

National Association for Dual Diagnosis (NADD) (USA)

Lead: Section on Conduct Disorder for Diagnostic Manual-Intellectual Disability-version 2; DMID-2 (adaption of DSM5 for ID).

Member: Section on Neurocognitive Disorders for DMID-2.

World Psychiatric Association (WPA) (Ex)

Co-Chair: Section on Psychiatry of Intellectual Disabilities (SPID).

Lead: International Guide for pharmacological interventions for problem behaviours in adults with ID.

European Association for Mental Health in ID (EAMHID) (Ex)

Lead: European Guide for Assessment and Diagnosis of Mental Disorders in ID (translated into many languages). www.iamhid.org
National (Ex)

NICE UK Guideline Development Groups member.

NIHR grant panel member.

NIHR Research Fellow.

Royal College of Psychiatrists (Ex)

Lead: National Guide on use of medication for the management of problem behaviours in adults with ID. http://www.ld-medication.bham.ac.uk

Research Lead: ID Faculty.

Member: College Education and Training Committee.

Lead: Curriculum development for Neuropsychiatry training.

Executive Committee member: ID Faculty.

Executive Committee member: Neuropsychiatry Faculty.

Research Lead: Neuropsychiatry Faculty.

Lead: Development of evidence base for the management of problem behaviour in ID.

University of Birmingham (Ex)

a) MSc Programme Director: Epilepsy.

b) MSc Module lead: Neuropsychiatry.

c) MSc Module lead: Intellectual Disability.

d) Programme Director: ID Psychiatry training West Midlands Deanery.

e) Lead: Guide for transition services for people with problem behaviour in ID. http://ldtransitionguide.bham.ac.uk

University of Cardiff (Ex)

a) MSc Programme Director: Psychiatry Psychological Medicine.

b) Vice Chair: Wales Psychiatric Training Committee.

c) Royal College Research Lead: Psychiatry in Wales.

d) Member: Team that developed first ever evidence-based practice manual for treatment in ID in the National Health Service, UK.

Developed Dementia Screening Questionnaire for Individuals with Intellectual Disability (DSQIID) which has been translated into more than 12 languages for world-wide use.

Developed first ever carer determined outcome measure for Patients with traumatic brain injury (TBI).